definiens: means all ONCOTHYREON PATENT RIGHTS and/or ONCOTHYREONKNOW - HOW in the FIELD ; 1.1.41 means May 7, 2001 ; 1.1.42 means a chemical precursor of PRODUCT which is to be cleaved in a human being directly intoPRODUCT and/or a metabolic intermediate thereof, but excluding for greater certainty, antigen processing ; 1.1.43 shall mean BLP25 ; 1.1.44 has the meaning attributed to that term in section 2.7.2 of this AGREEMENT ; 1.1.45 shall mean all countries in the world except the NA TERRITORY ; 1.1.46 includes, with respect to PRODUCT, the sale thereof to an END USER, and and have acorresponding meaning ; 1.1.47 has the meaning attributed to that term in section 7.2 of this AGREEMENT ; 1.1.48 has the meaning attributed to that term in section 5.12.5 of this AGREEMENT ; 1.1.49 has the meaning attributed to that term in section 5.12.1 of this AGREEMENT ; 1.1.50 shall mean, collectively, the NA TERRITORY and the ROW TERRITORY ; 1.1.51 means, collectively, the ICRT LICENSE, the DANA - FARBER LICENSE, the U of ALICENSE, the CORIXA LICENSE and any other third party license or sublicense of any technology included aspart of the ONCOTHYREON TECHNOLOGY ; 1.1.52 means the trademarks and logos initially selected for BLP25 pursuant to section 5.12 of thisAGREEMENT, being the trademarks STIMUVAX, STENVAX, STIMRIS, SIATOPE, THEXOPE and JEXAVE ; 1.1.53 has the meaning attributed to that term in section 5.12.5 of thisAGREEMENT ; + DESIGNATES PORTIONS OF THIS DOCUMENT THAT HAVE BEEN OMITTED PURSUANT TO A REQUEST FORCONFIDENTIAL TREATMENT FILED SEPARATELY WITH THE COMMISSION 8 1.1.54 has the meaning attributed to that term in section 2.7.2 of this AGREEMENT ; 1.1.55 has the meaning attributed to that term in section 2.7.2 of this AGREEMENT ; 1.1.56 means that certain license dated December 1, 2001 with the University of Alberta in relation tothe Samuels MUC1 liposomal formulation patents, together with all schedules thereto and any amendments to orrestatements of such license agreement ; and 1.1.57 means, with respect to PRODUCT in a particular country in the TERRITORY, a claim of anissued and unexpired patent included within the ONCOTHYREON PATENT RIGHTS which has not been heldunenforceable, unpatentable or invalid by a decision of a court or other governmental agency of competentjurisdiction, unappealable or unappealed within the time allowed for appeal, and which has not been admitted tobe invalid or unenforceable through reissue, disclaimer or otherwise